Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1291554

GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review

Description:

Summary

GlaxoSmithKline plc (GSK) is a healthcare company. It focuses on the development, manufacture and commercialization of pharmaceutical and consumer health related products. The company offers medicines for the treatment of various diseases such as infections, asthma, diabetes, cardiovascular, mental health and digestive conditions. Its research and development activities focus on the development of medicines and vaccines for HIV/AIDS, tuberculosis and malaria. The company also offers antiviral drugs, vaccines, consumer healthcare products and medicines for asthma, cardiovascular and digestive conditions, diabetes, infections and mental health. It also operates research facilities in the UK, the US, Belgium, Spain, and China. GSK is headquartered in Middlesex, the UK.

GSK aims at offering high quality medicines and vaccines to enhance the quality of human life around the world. Its strategy is to improve long-term financial performance with a diversified business model, enhance R&D returns, and deliver a diverse line of products, while simplifying its operating model. The company also aims at maintaining its existing partnerships and entering into new collaborative agreements to augment its services.

GlaxoSmithKline plc Key Recent Developments

Apr 08, 2013 GSK Officially Opens New Office In Navy Yard Corporate Center, Philadelphia
Mar 26, 2013 Texas A&M University And GSK Receive US Approval To Establish $91m Influenza Vaccine Facility In Texas
Mar 20, 2013 GSK Publishes 2012 Corporate Responsibility Report
Mar 12, 2013 Interpol And Pharmaceutical Industry Launch Global Initiative To Combat Fake Medicines

This comprehensive SWOT profile of GlaxoSmithKline plc provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Contents:

List of Tables
List of Figures
Section 1 - About the Company
GlaxoSmithKline plc - Key Facts
GlaxoSmithKline plc - Key Employees
GlaxoSmithKline plc - Key Employee Biographies
GlaxoSmithKline plc - Major Products and Services
GlaxoSmithKline plc - Pharmaceutical Pipeline Products Data
GlaxoSmithKline plc, Pipeline Products by Therapy Area
GlaxoSmithKline plc, Pipeline Products by Development Phase
GlaxoSmithKline plc - Medical Equipment Pipeline Products Data
GlaxoSmithKline plc Pipeline Products by Equipment Type
GlaxoSmithKline plc Pipeline Products by Development Stage
GlaxoSmithKline plc - History
GlaxoSmithKline plc - Company Statement
GlaxoSmithKline plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
GlaxoSmithKline plc - Key Manufacturing Facilities
Section 2 – Company Analysis
GlaxoSmithKline plc - Business Description
GlaxoSmithKline plc - Corporate Strategy
GlaxoSmithKline plc - SWOT Analysis
SWOT Analysis - Overview
GlaxoSmithKline plc - Strengths
Strength - Widespread Geographical Presence
Strength - Focused Research and Development Capabilities
Strength - Diversified Product Portfolio
GlaxoSmithKline plc - Weaknesses
Weakness - Product Liability Claims
GlaxoSmithKline plc - Opportunities
Opportunity - Late Stage Pipeline Products
Opportunity - Strategic Agreements
Opportunity - Changing Demographics
GlaxoSmithKline plc - Threats
Threat - Government Regulations
Threat - Uncertain R&D Outcomes
Threat - Competitive Pressures
GlaxoSmithKline plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
GlaxoSmithKline plc, Medical Equipment, Deals By Year, 2007 to YTD 2013
GlaxoSmithKline plc, Medical Equipment, Deals By Type, 2007 to YTD 2013
GlaxoSmithKline plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
GlaxoSmithKline plc, Recent Developments
Apr 08, 2013: GSK Officially Opens New Office In Navy Yard Corporate Center, Philadelphia
Mar 26, 2013: Texas A&M University And GSK Receive US Approval To Establish $91m Influenza Vaccine Facility In Texas
Mar 20, 2013: GSK Publishes 2012 Corporate Responsibility Report
Mar 12, 2013: Interpol And Pharmaceutical Industry Launch Global Initiative To Combat Fake Medicines
Mar 12, 2013: GSK To Shutdown Sirtris Pharma's Cambridge Headquarters, Relocates Some Staff To Philadelphia
Mar 12, 2013: GlaxoSmithKline To Combine Employees From Several Facilities In Suburban Philadelphia
Mar 02, 2013: GSK Files Lawsuit Against Hospira Over Quality Of Flu Vaccine
Feb 19, 2013: GSK To Close Financial Services Unit In Cork, Ireland And Eliminate 94 Jobs
Feb 15, 2013: GSK Extends Contract With Genpact For Finance And Accounting Business Process Management Services
Feb 06, 2013: GSK Reports Revenue Of £6.8 Billion In Q4 2012
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
GlaxoSmithKline plc, Key Facts
GlaxoSmithKline plc, Key Employees
GlaxoSmithKline plc, Key Employee Biographies
GlaxoSmithKline plc, Major Products and Services
GlaxoSmithKline plc, Number of Pipeline Products by Therapy Area
GlaxoSmithKline plc, Number of Pipeline Products by Development Stage
GlaxoSmithKline plc, Pipeline Products By Therapy Area and Development Phase
GlaxoSmithKline plc Number of Pipeline Products by Equipment Type
GlaxoSmithKline plc Pipeline Products by Equipment Type
GlaxoSmithKline plc Number of Pipeline Products by Development Stage
GlaxoSmithKline plc Pipeline Products by Development Stage
GlaxoSmithKline plc, History
GlaxoSmithKline plc, Other Locations
GlaxoSmithKline plc, Subsidiaries
GlaxoSmithKline plc, Key Manufacturing Facilities
GlaxoSmithKline plc, Key Competitors
GlaxoSmithKline plc, Ratios based on current share price
GlaxoSmithKline plc, Annual Ratios
GlaxoSmithKline plc, Interim Ratios
GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
GlaxoSmithKline plc, Medical Equipment, Deals By Year, 2007 to YTD 2013
GlaxoSmithKline plc, Medical Equipment, Deals By Type, 2007 to YTD 2013
GlaxoSmithKline plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
GlaxoSmithKline plc, Pipeline Products by Therapy Area
GlaxoSmithKline plc, Pipeline Products by Development Phase
GlaxoSmithKline plc Pipeline Products by Equipment Type
GlaxoSmithKline plc Pipeline Products by Development Stage
GlaxoSmithKline plc, Performance Chart (2008 - 2012)
GlaxoSmithKline plc, Ratio Charts
GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
GlaxoSmithKline plc, Medical Equipment, Deals By Year, 2007 to YTD 2013
GlaxoSmithKline plc, Medical Equipment, Deals by Type, 2007 to YTD 2013

Companies Mentioned

Novartis AG
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Amgen Inc.
Sanofi-Aventis
AstraZeneca PLC

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/1582661

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2

Printed Tuesday, May 21, 2013
10:12:41 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review

Web Address

http://www.researchandmarkets.com/reports/1291554

Office Code

OC8DIQSQNUNQSW

Report Formats

Please enter the quantity of the report format you require.

Format	Quantity	Price
Electronic (PDF) - Single User		EURO€ 96.00
Electronic (PDF) - Site License		EURO€ 192.00
Electronic (PDF) - Enterprisewide		EURO€ 288.00

Contact information

Please enter all the information below in block capitals.

                Title:
            
                    Mr
                    
                    Mrs
                    
                    Dr
                    
                    Miss
                    
                    Ms
                    
                    Prof
                    
                First Name:
            
                Last Name:
                
                Email Address:
            
                Job Title:
            
                Organisation:
            
                Address:
            
                City:
            
                Postal / Zip Code:	
            
                Country:	
            
                Phone Number:	
            
                Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2

Printed Tuesday, May 21, 2013
10:12:41 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:

Cardholder's Signature:

Expiry Date:

Card Number:

CVV Security Code:

Issue date:

(Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:

Account Number:

83313083

Sort Code:

98-53-30

Swift Code:

ULSBIE2D

IBAN Number:

IE78ULSB98533083313083

Bank Address:

Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Printer Friendly

GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review

Fax order form

Order information

Product name

Web Address

Office Code

Report Formats

Contact information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Payment information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)